ATRC
AtriCure IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$1.45B
P/E Ratio
—
EPS
$-0.24
Beta
1.43
52W High
$43.18
52W Low
$27.31
50-Day MA
$32.45
200-Day MA
$34.90
Dividend Yield
—
Profit Margin
-2.14%
Forward P/E
384.62
PEG Ratio
10.00
About AtriCure Inc
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.
Fundamentals
| Revenue (TTM) | $534.53M |
| Gross Profit (TTM) | $400.78M |
| EBITDA | $11.08M |
| Operating Margin | 1.77% |
| Return on Equity | -2.40% |
| Return on Assets | -0.94% |
| Revenue/Share (TTM) | $11.19 |
| Book Value | $9.88 |
| Price-to-Book | 2.94 |
| Price-to-Sales (TTM) | 2.72 |
| EV/Revenue | 2.533 |
| EV/EBITDA | 83.34 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 13.10% |
| Shares Outstanding | $49.81M |
| Float | $47.76M |
| % Insiders | 3.74% |
| % Institutions | 101.15% |
Analyst Ratings
Consensus ($47.88 target)
3
Strong Buy3
Buy2
HoldData last updated: 4/7/2026